Literature DB >> 11921198

Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.

Masao Hirose1, Akiyoshi Nishikawa, Makoto Shibutani, Toshio Imai, Tomoyuki Shirai.   

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is one of the most prevalent carcinogenic heterocyclic amines in the environment, targeting the colon, prostate, pancreas, and mammary gland in rodents. Chemopreventive effects of synthetic and naturally occurring compounds on PhIP-induced rat mammary carcinogenesis were investigated in a series of experiments. In a PhIP feeding model, groups of 20-21 female F344 rats each, were treated with 0.02% PhIP alone or PhIP plus 0.5% 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), 1% green tea catechins, 1% alpha-tocopherol, 0.1% ellagic acid, or 1% chlorophyllin, each in the diet, or 0.1% caffeine in drinking water for 52 weeks. To assess the mechanism of HTHQ and caffeine inhibition of PhIP-induced carcinogenesis, effects of these compound on the in vitro metabolic activation of PhIP were examined in the presence of S9 mix. In the next series of experiments, the PhIP intragastric dose model was applied to allow separate investigation of the effects of chemicals during the initiation and postinitiation periods. In these experiments, female Sprague-Dawley rats were given eight intragastric doses of 100 mg/kg body weight during the first 4-8 weeks for initiation. Either during initiation or after initiation, or only after initiation, animals were treated with either corn or perilla oil at doses of 5 and 20%, conjugated fatty acid derived from safflower oil (CFA-S) or perilla oil (CFA-P) at a dose of 1%, arctiin at doses of 0.02 and 0.2% in the diet, or sodium nitrite (NaNO(2)) at a dose of 0.2% in drinking water. In the PhIP feeding model, administration of PhIP alone for 52 weeks induced adenocarcinomas in 40% of rats, but the incidence was remarkably reduced to 5% by the simultaneous treatment with 0.5% HTHQ, a strong lipophilic phenolic antioxidant, or to 10% by 0.1% caffeine. Administration of 1% chlorophyllin exerted similar, albeit weaker, effects. alpha-Tocopherol at a dose of 0.5% only reduced the multiplicity of carcinomas, and 1% green tea catechins only the mean size of mammary tumors. In a metabolic activation study of PhIP, HTHQ and caffeine clearly inhibited the formation of metabolites. In the PhIP gastric dose model, among the naturally occurring compounds examined, a plant lignan arctiin, perilla oil, which contains a large amount of n-6 alpha-linolenic acid, and CFA-S or CFA-P inhibited mammary tumor development, particularly in the postinitiation period, although a clear dose response was not observed. Treatment with 0.2% NaNO(2) in the initiation period was found to lower the volume of mammary tumors. The present results indicate that a number of compounds may be candidate chemopreventive agents against PhIP-induced mammary carcinogenesis, acting through different mechanisms and depending on the stage of carcinogenesis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11921198     DOI: 10.1002/em.10066

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  10 in total

1.  Cancer chemoprevention by dietary chlorophylls: a 12,000-animal dose-dose matrix biomarker and tumor study.

Authors:  Tammie J McQuistan; Michael T Simonich; M Margaret Pratt; Cliff B Pereira; Jerry D Hendricks; Roderick H Dashwood; David E Williams; George S Bailey
Journal:  Food Chem Toxicol       Date:  2011-11-03       Impact factor: 6.023

Review 2.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

Review 3.  Green tea compounds in breast cancer prevention and treatment.

Authors:  Min-Jing Li; Yan-Cun Yin; Jiao Wang; Yang-Fu Jiang
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Prevention of coronary heart disease and cancer by tea, a review.

Authors:  John H Weisburger
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

5.  Chlorophyllin abrogates canonical Wnt/β-catenin signaling and angiogenesis to inhibit the development of DMBA-induced hamster cheek pouch carcinomas.

Authors:  Siddavaram Nagini; Nagini Siddavaram; Ramamurthi Vidya Priyadarsini; Vidya Priyadarsini Ramamurthi; Veeran Veeravarmal; Veeravarmal Veeran; Rajakishore Mishra
Journal:  Cell Oncol (Dordr)       Date:  2012-09-15       Impact factor: 6.730

6.  A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice.

Authors:  Jihyeung Ju; Xingpei Hao; Mao-Jung Lee; Joshua D Lambert; Gang Lu; Hang Xiao; Harold L Newmark; Chung S Yang
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-20

Review 7.  Cancer-preventive activities of tocopherols and tocotrienols.

Authors:  Jihyeung Ju; Sonia C Picinich; Zhihong Yang; Yang Zhao; Nanjoo Suh; Ah-Ng Kong; Chung S Yang
Journal:  Carcinogenesis       Date:  2009-09-11       Impact factor: 4.944

Review 8.  The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer.

Authors:  Yi-Hsuan Hsiao; Chiao-Wen Lin; Po-Hui Wang; Min-Chien Hsin; Shun-Fa Yang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

9.  Modelling the Effects of Roselle Extract, Potato Peel Flour, and Beef Fat on the Sensory Properties and Heterocyclic Amines Formation of Beef Patties Studied by Using Response Surface Methodology.

Authors:  Anna Judith Pérez-Báez; Martin Valenzuela-Melendres; Juan Pedro Camou; Gustavo González-Aguilar; Orlando Tortoledo-Ortiz; Humberto González-Ríos; Manuel Viuda-Martos
Journal:  Foods       Date:  2021-05-25

10.  Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action.

Authors:  Miki Tsujita-Kyutoku; Takashi Yuri; Naoyuki Danbara; Hideto Senzaki; Yasuhiko Kiyozuka; Norihisa Uehara; Hideho Takada; Takahiko Hada; Teruo Miyazawa; Yutaka Ogawa; Airo Tsubura
Journal:  Breast Cancer Res       Date:  2004-04-26       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.